Evidence map›Paper›PMID 35851672›Full record

ArticleDrug delivery and translational research2023

The impact of varying dextran oxidation levels on the inhibitory activity of a bacteriocin loaded injectable hydrogel.

James Flynn, Mario Culebras, Maurice N Collins, Sarah P Hudson

Open access · hybridAbstract read
In one paragraph

Article in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

James FlynnDepartment of Chemical Sciences, Bernal Institute, SSPC - The SFI Pharmaceutical Research Centre, University of Limerick, Limerick, Ireland.
Mario CulebrasSchool of Engineering, Stokes Laboratories, Bernal Institute, University of Limerick, Limerick, Ireland.
Maurice N CollinsSchool of Engineering, Stokes Laboratories, Bernal Institute, University of Limerick, Limerick, Ireland.
Sarah P HudsonDepartment of Chemical Sciences, Bernal Institute, SSPC - The SFI Pharmaceutical Research Centre, University of Limerick, Limerick, Ireland. Sarah.Hudson@ul.ie.ORCID 0000-0002-6718-2190
University of Limerick · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the design of injectable antimicrobial dextran-alginate hydrogels, the impact of dextran oxidation and its subsequent changes in molecular weight and the incorporation of glycol chitosan on (i) gel mechanical strength and (ii) the inhibitory profile of an encapsulated bacteriocin, nisin A, are explored. As the degree of oxidation increases, the weight average molecular mass of the dextran decreases, resulting in a reduction in elastic modulus of the gels made. Upon encapsulation of the bacteriocin nisin into the gels, varying the dextran mass/oxidation level allowed the antimicrobial activity against S. aureus to be controlled. Gels made with a higher molecular weight (less oxidised) dextran show a higher initial degree of inhibition while those made with a lower molecular weight (more oxidised) dextran exhibit a more sustained inhibition. Incorporating glycol chitosan into gels composed of dextran with higher masses significantly increased their storage modulus and the gels' initial degree of inhibition.

Indexed as

Anti-Infective AgentsBacteriocinsDextransHydrogelsStaphylococcus aureusAnti-Infective AgentsBacteriocinsDextransHydrogelsAntimicrobialBacteriocinsControlled releaseDrug deliveryHydrogelPolysaccharides

Identifiers

PMID35851672
PMCPMC9726672
OpenAlexW4285726258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.